| Identification | Back Directory | [Name]
L-Glutamic acid, glycyl-L-lysyl-L-valyl-L-leucyl-L-seryl-L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-asparaginyl-L-lysyl- | [CAS]
1026775-53-0 | [Synonyms]
L-Glutamic acid, glycyl-L-lysyl-L-valyl-L-leucyl-L-seryl-L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-asparaginyl-L-lysyl- | [Molecular Formula]
C60H102N16O17 | [MOL File]
1026775-53-0.mol | [Molecular Weight]
1319.55 |
| Chemical Properties | Back Directory | [Boiling point ]
1678.2±65.0 °C(predicted) | [density ]
1.253±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [pka]
3.16±0.10(predicted) | [Sequence]
Gly-Lys-Val-Leu-Ser-Lys-Ile-Phe-Gly-Asn-Lys-Glu |
| Hazard Information | Back Directory | [Uses]
ARF6 (2-13) is a peptide with a sequence of GKVLSKIFGNKE. ARF6 (2-13) is an inhibitor of ARF6. ARF6 (2-13) can be used in the research of endotoxemia[1]. | [References]
[1] Chadwick T Davis, et al. ARF6 inhibition stabilizes the vasculature and enhances survival during endotoxic shock. J Immunol. 2014, 192, 12. DOI:10.4049/jimmunol.1400309 |
|
|